Cargando…

Long-term follow-up of systemic onset juvenile idiopathic arthritis patients treated with Anakinra

Detalles Bibliográficos
Autores principales:	Gattorno, Marco, Naselli, Aldo, Accogli, Andrea, Chiesa, Sabrina, Caorsi, Roberta, Tebaldi, Jessica, Buoncompagni, Antonella, Ruperto, Nicola, Viola, Stefania, Picco, Paolo, Ravelli, Angelo, Martini, Alberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194511/ http://dx.doi.org/10.1186/1546-0096-9-S1-P158

Ejemplares similares

PW01-039 – Long-term efficacy of anakinra in SoJIA patients
por: Naselli, A, et al.
Publicado: (2013)

Agreement between physicians and parents in rating functional ability of children with juvenile idiopathic arthritis
por: Palmisani, Elena, et al.
Publicado: (2007)

Impact of involvement of individual joint groups on subdimensions of functional ability scales in juvenile idiopathic arthritis
por: Meiorin, S, et al.
Publicado: (2008)

Chronic active EBV infection mimicking periodic fever syndromes: a new challenge for the paediatrician
por: Caorsi, Roberta, et al.
Publicado: (2014)

Whole-body MRI as an unconventional diagnostic tool in a pediatric patient with systemic infection
por: Picco, Paolo, et al.
Publicado: (2014)

PW02-010 - The diagnostic challenge of bone lesions in AID
por: Caorsi, R, et al.
Publicado: (2013)

PReS-FINAL-2237: The diagnostic challenge of osteolytic bone lesions in autoinflammatory diseases: a case report
por: Caorsi, R, et al.
Publicado: (2013)

Long-term efficacy of etanercept in ADA2 deficiency
por: Caorsi, Roberta, et al.
Publicado: (2014)

Is it worth including subtalar joint in ultrasound ankle assessment of patients with juvenile idiopathic arthritis?
por: Lanni, Stefano, et al.
Publicado: (2014)

A controlled trial of intra-articular corticosteroids with or without methotrexate in oligoarticular juvenile idiopathic arthritis
por: Bracciolini, GP, et al.
Publicado: (2014)

Efficacy of anakinra on rebound of multisystem inflammatory syndrome
por: Brisca, Giacomo, et al.
Publicado: (2022)

Role of IL-1 Beta in the Development of Human T(H)17 Cells: Lesson from NLPR3 Mutated Patients
por: Lasigliè, Denise, et al.
Publicado: (2011)

Juvenile eosinophilic fasciitis: report of three cases with a review of the literature
por: Papa, R, et al.
Publicado: (2015)

Enlarging the clinical spectrum of SAVI syndrome
por: Caorsi, R, et al.
Publicado: (2015)

Safety and efficacy of early high-dose IV anakinra in severe COVID-19 lung disease
por: Pontali, Emanuele, et al.
Publicado: (2020)

PW03-018 – Efficacy of Anakinra in recurrent pericarditis
por: Finetti, M, et al.
Publicado: (2013)

2.4 Magnetic resonance imaging, ultrasonography and conventional radiography in the assessment of bone erosions in juvenile idiopathic arthritis
por: Malattia, C, et al.
Publicado: (2008)

Development and initial validation of the parent acceptable symptom state in juvenile idiopathic arthritis (JIA)
por: Filocamo, G, et al.
Publicado: (2008)

Do parent's global rating of well-being and disease activity of children with juvenile idiopathic arthritis yield different information?
por: Ullmann, N, et al.
Publicado: (2008)

Anakinra treatment in patients with systemic-onset juvenil idiopathic arthritis: “The Valencia Experience”
por: Marvillet, I, et al.
Publicado: (2011)

PReS-FINAL-2333: Long term efficacy of interleukin-1 receptor antagonist (anakinra) in a multicentric cohort of patients affected by idiopathic recurrent pericarditis
por: Finetti, M, et al.
Publicado: (2013)

PW02-005 - A web registry of genotype-phenotype correlation
por: Doglio, M, et al.
Publicado: (2013)

Musculoskeletal ultrasound versus magnetic resonance in supporting clinical management of juvenile idiopathic arthritis
por: Lanni, Stefano, et al.
Publicado: (2014)

Current Medical Treatments for Juvenile Idiopathic Arthritis
por: Ruperto, Nicolino, et al.
Publicado: (2011)

Sensitivity and specificity of current diagnostic guidelines in children with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
por: Davì, Sergio, et al.
Publicado: (2011)

Sensitivity and specificity of current diagnostic guidelines in children with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
por: Davì, Sergio, et al.
Publicado: (2011)

Rapid and sustained effect of anti-TNF treatment in patients with ADA2 deficiency
por: Caorsi, R, et al.
Publicado: (2015)

Long-term efficacy of IL-1 blockers in PAPA patients
por: Finetti, M, et al.
Publicado: (2015)

Anakinra pharmacokinetics in children and adolescents with systemic-onset juvenile idiopathic arthritis and autoinflammatory syndromes
por: Urien, Saik, et al.
Publicado: (2013)

A meta-analysis to estimate the “real” placebo effect in juvenile idiopathic arthritis (JIA) trials
por: Demirkaya, E, et al.
Publicado: (2011)

Analysis of ceiling effect and score distribution of outcome measures in juvenile idiopathic arthritis (JIA)
por: Lattanzi, B, et al.
Publicado: (2008)

PReS-FINAL-2132: Defining criteria for high disease activity in juvenile idiopathic arthritis: definition and validation of juvenile arthritis disease activity score cutoffs
por: Consolaro, A, et al.
Publicado: (2013)

Successful treatment of refractory hyperferritinemic syndromes with canakinumab: a report of two cases
por: Papa, Riccardo, et al.
Publicado: (2020)

3.5 Comparison of functional ability in juvenile idiopathic arthritis, juvenile dermatomyositis, juvenile systemic lupus erythematosus and healthy controls. An analysis of the PRINTO database
por: Filocamo, G, et al.
Publicado: (2008)

Treating to target of minimal disease activity and normal function in polyarticular juvenile idiopathic arthritis with adalimumab: analysis from a phase 3 clinical trial
por: Ruperto, Nicola, et al.
Publicado: (2014)

Anakinra for systemic onset juvenile idiopathic arthritis: experience as a second versus first line treatment
por: Ricart, S, et al.
Publicado: (2011)

Predictive Value of Magnetic Resonance Imaging in Patients With Juvenile Idiopathic Arthritis in Clinical Remission
por: Mazzoni, Marta, et al.
Publicado: (2022)

Anakinra in systemic juvenile idiopathic arthritis (soJIA) non responsive to antiTNF
por: Pontikaki, I, et al.
Publicado: (2008)

An Economic Comparison of Treatment Strategies with Anakinra in Systemic Juvenile Idiopathic Arthritis (sJIA)
por: Bullement, Ash, et al.
Publicado: (2021)

Type I interferonopathies in pediatric rheumatology
por: Volpi, Stefano, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_johs3k2nfq6gpvgeqi0e61od9u